PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Oct-2025 PandaDoc Introduces CFR Part 11 Workspaces for Regulated E-Signature Workflows Businesswire
01-Oct-2025 Mammoth Biosciences to Present Preclinical Data on MB-111 at the European Society of Gene & Cell Therapy 32nd Annual Congress Businesswire
01-Oct-2025 Gay Ad Network Launches First LGBTQ+ Digital Out-of-Home Advertising Solution Newswire
01-Oct-2025 Lord Hague of Richmond officially opens £1.2 billion Oxford North flagship global innovation district in major boost to UK science, technology & AI sectors Oxford North
01-Oct-2025 L&T Technology Services Wins USD 100 Million Multi-Year Program from US-Based Industrial Equipment Manufacturer Businesswire
01-Oct-2025 Enanta Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock Businesswire
01-Oct-2025 Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes Businesswire
30-Sep-2025 Ambulatory Surgical and Emergency Centers Market 2024-2032: Size, Growth Drivers & Key Trends Ameco Research
30-Sep-2025 Smart Contact Lenses Market Outlook 2025–2032: Innovations, Growth Drivers & Industry Insights Ameco Research
29-Sep-2025 Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model Genmab A/S
24-Sep-2025 South Africa Pharmaceutical Industry Report 2025 | Market Concentration and Price Regulations Pose Challenges for South Africa's Pharma Sector - ResearchAndMarkets.com Businesswire
24-Sep-2025 United States Next Generation Sequencing (NGS) Market Research 2025-2033: Personalized Medicine, Research Applications, and Advances in Automation Propel Growth - ResearchAndMarkets.com Businesswire
24-Sep-2025 TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing Businesswire
24-Sep-2025 ICON plc Schedules Third Quarter 2025 Earnings Conference Call Businesswire
24-Sep-2025 Aro Biotherapeutics Completes Enrollment in Phase 1b Trial of Targeted siRNA Therapy, ABX1100, in Late-Onset Pompe Disease (LOPD) Businesswire
24-Sep-2025 Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome Businesswire
24-Sep-2025 Kashiv BioSciences and JAMP Pharma Corporation Announce the Launch of PEXEGRA® and FILRA® Biosimilars in Canada Businesswire
24-Sep-2025 Accellix, Inc. and Streck Collaborate to Advance Cell Therapy with Quality Control Businesswire
24-Sep-2025 TruTechnologies Appoints Mirador Therapeutics Executive Jordan Zwick to Board of Directors Businesswire
24-Sep-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire